Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 16,825-16,836 of 23,847
Drug study icon
CompletedNCT05185583

Methylphenidate in Childhood Apraxia of Speech

This summary needs review. Please check the official study record and contact the research team for details.

In Parkville
ADHDDrugA study involving a medication or substance.From 6 Years to 12 Years
Countries
Australia
Sponsor
Murdoch Childrens Research Institute
Condition
ADHD
Drug study icon
CompletedNCT00015223

Methylphenidate in the Treatment of Cocaine Dependent people with Adult Attention Deficit Hyperactivity Disorder - 5

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

In Cincinnati
ADHD, AddictionDrugFrom 21 Years to 50 Years
Countries
United States
Sponsor
National Institute on Drug Abuse (NIDA)
Condition
ADHD, Addiction
Drug study icon
CompletedNCT00506285

Methylphenidate Transdermal System (MTS) in the Treatment of Adult ADHD

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

In Salt Lake City
ADHDDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Utah
Condition
ADHD
Drug study icon
CompletedNCT00136734

Methylphenidate Treatment for Cocaine Abuse and ADHD - 1

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can play a useful role in care. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

In New York
ADHDDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
ADHD
Drug study icon
CompletedNCT02178995

Methylphenidate Treatment of Attention Deficits in Epilepsy

This study exists to understand whether smoking support or smoking-related treatment is both safe enough and useful enough to take further. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.

In Palo Alto
ADHDDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Kimford Jay Meador
Condition
ADHD
Drug study icon
OngoingEUCTR 2007-000137-19

Metyrapone as additive treatment in people with major depression

This study is looking at whether Metopiron can help people with unipolar depressive episode without psychotic features according to DSM-IV-TR. Participants receive the study medicine Metopiron and complete study visits and assessments.

In Netherlands
Depression, SchizophreniaOther
Countries
Netherlands
Sponsor
Leiden University Medical Center
Condition
Depression, Schizophrenia
Other study type icon
CompletedNCT05195684

MGH Trauma-related Nightmares SDI Study

This summary needs review. Please check the official study record and contact the research team for details.

In Charlestown
PTSDOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
PTSD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.